Literature DB >> 12142970

[Cerebral protection devices for treatment of carotid stenoses: Where do we stand today?].

S Müller-Hülsbeck1.   

Abstract

The carotid bifurcation is currently a subject of controversial discussion within the vascular territory. These controversies are obvious for diagnostic imaging but the more so for therapy. Performing stenting as a treatment tool, controversies exist also as to whether angioplasty is performed without or obligatory with cerebral protection. Théron and colleagues first described the concept of cerebral protection during carotid angioplasty and stent placement. Currently, there are three temporary cerebral protection systems, i. e. balloon occlusion, filtration baskets, and systems for flow reversal in the internal carotid artery. While these systems provide a considerable degree of protection, as has been shown in in vitro and preliminary clinical studies, embolization might still occur, even under protection. In addition, it is still not clear what the minimum size of emboli is that need to be stopped to prevent a stroke, and what the relevance of cerebral microemboli is. Clinical evidence suggests that the usage of protection systems favours a good outcome of the intervention; however, whether or not such systems should be used routinely remains a matter of discussion and should thus be verified in further clinical studies.

Entities:  

Mesh:

Year:  2002        PMID: 12142970     DOI: 10.1055/s-2002-32934

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  2 in total

Review 1.  [Proximal protection systems using carotid artery stent].

Authors:  I Q Grunwald; U Dorenbeck; C Axmann; C Roth; T Struffert; W Reith
Journal:  Radiologe       Date:  2004-10       Impact factor: 0.635

2.  Lesion-Related Carotid Angioplasty and Stenting with Closed-Cell Design without Embolic Protection Devices in High-Risk Elderly Patients-Can This Concept Work Out? A Single Center Experience Focusing on Stent Design.

Authors:  Silke Hopf-Jensen; Leonardo Marques; Michael Preiß; Stefan Müller-Hülsbeck
Journal:  Int J Angiol       Date:  2014-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.